Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic H...

por Paracha, Noman, Reyes, Adriana, Diéras, Véronique, Krop, Ian, Pivot, Xavier, Urruticoechea, Ander
Publicado 2020

Integrative analysis of a cancer somatic mutome

por Hernández, Pilar, Solé, Xavier, Valls, Joan, Moreno, Víctor, Capellá, Gabriel, Urruticoechea, Ander, Pujana, Miguel Angel
Publicado 2007

Genetic interactions: the missing links for a better understanding of cancer susceptibility, progression and treatment

por Maxwell, Christopher A, Moreno, Víctor, Solé, Xavier, Gómez, Laia, Hernández, Pilar, Urruticoechea, Ander, Pujana, Miguel Angel
Publicado 2008

Altered Red Blood Cell Membrane Fatty Acid Profile in Cancer Patients

por Amézaga, Javier, Arranz, Sara, Urruticoechea, Ander, Ugartemendia, Gurutze, Larraioz, Aitziber, Louka, Maria, Uriarte, Matxalen, Ferreri, Carla, Tueros, Itziar
Publicado 2018

Altered Levels of Desaturation and ω-6 Fatty Acids in Breast Cancer Patients’ Red Blood Cell Membranes

por Amézaga, Javier, Ugartemendia, Gurutze, Larraioz, Aitziber, Bretaña, Nerea, Iruretagoyena, Aizpea, Camba, Joana, Urruticoechea, Ander, Ferreri, Carla, Tueros, Itziar
Publicado 2020

Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: Utility of transcriptome analysis of the autophagy interactome to guide b...

por Cufí, Sílvia, Vazquez-Martin, Alejandro, Oliveras-Ferraros, Cristina, Corominas-Faja, Bruna, Urruticoechea, Ander, Martin-Castillo, Begoña, Menendez, Javier A.
Publicado 2012

A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines

por Puig, Teresa, Aguilar, Helena, Cufí, Sílvia, Oliveras, Glòria, Turrado, Carlos, Ortega-Gutiérrez, Sílvia, Benhamú, Bellinda, López-Rodríguez, María Luz, Urruticoechea, Ander, Colomer, Ramon
Publicado 2011

Early Detection of Brain Metastases in a Supervised Exercise Program for Patients with Advanced Breast Cancer: A Case Report

por PELAEZ, MIREIA, STUIVER, MARTIJN M., BROEKMAN, MARIKE, SCHMITZ, KATHRYN H., ZOPF, EVA M., CLAUSS, DOROTHEA, WENGSTRÖM, YVONNE, ROSENBERGER, FRIEDERIKE, STEINDORF, KAREN, URRUTICOECHEA, ANDER, MAY, ANNE M.
Publicado 2023

Molecular response to aromatase inhibitor treatment in primary breast cancer

por Mackay, Alan, Urruticoechea, Ander, Dixon, J Michael, Dexter, Tim, Fenwick, Kerry, Ashworth, Alan, Drury, Suzanne, Larionov, Alexey, Young, Oliver, White, Sharon, Miller, William R, Evans, Dean B, Dowsett, Mitch
Publicado 2007

Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis

por Martínez-Aranda, Antonio, Hernández, Vanessa, Moreno, Ferran, Baixeras, Núria, Cuadras, Daniel, Urruticoechea, Ander, Gil-Gil, Miguel, Vidal, Noemí, Andreu, Xavier, Seguí, Miquel A., Ballester, Rosa, Castella, Eva, Sierra, Angels
Publicado 2017

A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/201...

por Ocana, Alberto, Gil-Martin, Marta, Martín, Miguel, Rojo, Federico, Antolín, Silvia, Guerrero, Ángel, Trigo, José Manuel, Muñoz, Montse, Pandiella, Atanasio, Diego, Núria Gonzalo, Bezares, Susana, Caballero, Rosalía, Carrasco, Eva, Urruticoechea, Ander
Publicado 2017

Discovery and Proof-of-Concept Study of Nuclease Activity as a Novel Biomarker for Breast Cancer Tumors

por Hernandez, Luiza I., Araúzo-Bravo, Marcos J., Gerovska, Daniela, Solaun, Ricardo Rezola, Machado, Isabel, Balian, Alien, Botero, Juliana, Jiménez, Tania, Zuriarrain Bergara, Olaia, Larburu Gurruchaga, Lide, Urruticoechea, Ander, Hernandez, Frank J.
Publicado 2021

Biological Convergence of Cancer Signatures

por Solé, Xavier, Bonifaci, Núria, López-Bigas, Núria, Berenguer, Antoni, Hernández, Pilar, Reina, Oscar, Maxwell, Christopher A., Aguilar, Helena, Urruticoechea, Ander, de Sanjosé, Silvia, Comellas, Francesc, Capellá, Gabriel, Moreno, Víctor, Pujana, Miguel Angel
Publicado 2009

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies

por Martínez-Aranda, Antonio, Hernández, Vanessa, Guney, Emre, Muixí, Laia, Foj, Ruben, Baixeras, Núria, Cuadras, Daniel, Moreno, Víctor, Urruticoechea, Ander, Gil, Miguel, Oliva, Baldo, Moreno, Ferran, González-Suarez, Eva, Vidal, Noemí, Andreu, Xavier, Seguí, Miquel A., Ballester, Rosa, Castella, Eva, Sierra, Angels
Publicado 2015

Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymp...

por Goicoechea, Ibai, Rezola, Ricardo, Arestin, María, Caffarel, María M., Cortazar, Ana Rosa, Manterola, Lorea, Fernandez-Mercado, Marta, Armesto, María, Sole, Carla, Larrea, Erika, Araujo, Angela M., Ancizar, Nerea, Plazaola, Arrate, Urruticoechea, Ander, Carracedo, Arkaitz, Ruiz, Irune, Alvarez Lopez, Isabel, Lawrie, Charles H.
Publicado 2018

The Urinary Transcriptome as a Source of Biomarkers for Prostate Cancer

por Solé, Carla, Goicoechea, Ibai, Goñi, Alai, Schramm, Maike, Armesto, María, Arestin, María, Manterola, Lorea, Tellaetxe, Maitena, Alberdi, Aitor, Nogueira, Leonor, Roumiguie, Mathieu, López, Jose Ignacio, Sanz Jaka, Juan Pablo, Urruticoechea, Ander, Vergara, Itziar, Loizaga-Iriarte, Ana, Unda, Miguel, Carracedo, Arkaitz, Malavaud, Bernard, Lawrie, Charles H.
Publicado 2020

A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma

por Lopez, Juanita, Lai-Kwon, Julia, Molife, Rhoda, Welsh, Liam, Tunariu, Nina, Roda, Desamparados, Fernández-García, Paula, Lladó, Victoria, McNicholl, Adrian G., Rosselló, Catalina A., Taylor, Richard J., Azaro, Analía, Rodón, Jordi, Sludden, Julieann, Veal, Gareth J., Plummer, Ruth, Urruticoechea, Ander, Lahuerta, Ainhara, Mujika, Karmele, Escribá, Pablo V.
Publicado 2023

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population

por Gómez-Miragaya, Jorge, Palafox, Marta, Paré, Laia, Yoldi, Guillermo, Ferrer, Irene, Vila, Sergi, Galván, Patricia, Pellegrini, Pasquale, Pérez-Montoyo, Hector, Igea, Ana, Muñoz, Purificación, Esteller, Manel, Nebreda, Angel R., Urruticoechea, Ander, Morilla, Idoia, Pernas, Sonia, Climent, Fina, Soler-Monso, María Teresa, Petit, Ana, Serra, Violeta, Prat, Aleix, González-Suárez, Eva
Publicado 2017

A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer

por Pascual, Tomás, Martin, Miguel, Fernández-Martínez, Aranzazu, Paré, Laia, Alba, Emilio, Rodríguez-Lescure, Álvaro, Perrone, Giuseppe, Cortés, Javier, Morales, Serafín, Lluch, Ana, Urruticoechea, Ander, González-Farré, Blanca, Galván, Patricia, Jares, Pedro, Rodriguez, Adela, Chic, Nuria, Righi, Daniela, Cejalvo, Juan Miguel, Tonini, Giuseppe, Adamo, Barbara, Vidal, Maria, Villagrasa, Patricia, Muñoz, Montserrat, Prat, Aleix
Publicado 2019

Design of a multinational randomized controlled trial to assess the effects of structured and individualized exercise in patients with metastatic breast cancer on fatigue and quali...

por Hiensch, Anouk E., Monninkhof, Evelyn M., Schmidt, Martina E., Zopf, Eva M., Bolam, Kate A., Aaronson, Neil K., Belloso, Jon, Bloch, Wilhelm, Clauss, Dorothea, Depenbusch, Johanna, Lachowicz, Milena, Pelaez, Mireia, Rundqvist, Helene, Senkus, Elzbieta, Stuiver, Martijn M., Trevaskis, Mark, Urruticoechea, Ander, Rosenberger, Friederike, van der Wall, Elsken, de Wit, G. Ardine, Zimmer, Philipp, Wengström, Yvonne, Steindorf, Karen, May, Anne M.
Publicado 2022